Genomic characteristics associated with clinical activity of rucaparib in patients (pts) with BRCA1 or BRCA2 (BRCA)-mutated metastatic castration-resistant prostate cancer (mCRPC)-MedSci.cn

Genomic characteristics associated with clinical activity of rucaparib in patients (pts) with BRCA1 or BRCA2 (BRCA)-mutated metastatic castration-resistant prostate cancer (mCRPC)

Abida, W; Campbell, D; Patnaik, A; Sautois, B; Shapiro, JD; Vogelzang, NJ; Bryce, AH; McDermott, RS; Ricci, F; Rowe, JH; Zhang, JS; Loehr, A; Despain, D; Dowson, M; Golsorkhi, T; Chowdhury, S

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (6):

科室
- - 订阅+
  - 更多科室
工具
服务